Express Scripts Holding Company (ESRX) Should Continue Being Steady


Express Scripts Holding Company (NASDAQ:ESRX) is one of those companies which usually report earnings in line with the analysts’ expectations. The company is not only set to benefit from from Obamacare but It was also the solution provider to address important avenues to improve care, as well as, cut down the expenses for patients who spend high medical costs.

Key Factors

Express Scripts Holding Company (NASDAQ:ESRX) takes every turn to add value to the healthcare by achieving a higher model of patient care with forceful payer advocacy. The company believes that its combination of unmatched will, scale, and client alignment have consistently created superior value for its patients, as well as, payers. The pharmacy operator claims that its client retention commences with an easy concept of patient care.

Pharmacy care is growing due to the increasing number of patients for different ailments. For instance, close to 600,000 people have annual medication expenses of $50,000 in the United States. The number of patients taking a minimum of $100,000 worth of prescriptions drugs has tripled in 2014. The majority of the patients were taking a minimum of 10 medications from four different prescribers. The company is known for addressing critical opportunities to enhance the patient care and at the same time reduce expenses for patients with superior medication costs. These were drivers for revenue generation for Express Scripts Holding Company (NASDAQ:ESRX).

Expectations

While releasing the first quarter results, the company indicated adjusted earnings to be $1.39 – $1.43 a share for the second quarter representing 13 – 16% YOY growth. That means the mid-point of $1.41 a share is higher than the Street analysts’ expectations of $1.40 a share. In the last two months, analysts’ have not revised their EPS estimations for the company.

Analysts also expect Express Scripts Holding Company (NASDAQ:ESRX) to witness 4% revenue growth to $26.13 billion in the June quarter. The company is also known for its disciplined approach, and that might take them to deliver either in line or slightly above the expected results.

Viraj Shah

Viraj Shah has completed M.Com (Finance) and is currently pursuing his CFP. He tracks US markets along with other global markets like India very closely. He is very passionate about stocks, real estate, and technology. He also believes that money can always be made in the market.

You may also like...

Read previous post:
E I Du Pont De Nemours And Co (NYSE:DD)
Impact Of Foreign Currency Will Be Key For E I Du Pont De Nemours And Co (DD)

E I Du Pont De Nemours And Co (NYSE:DD) has delivered earnings either in line with or above the expectations...

Close